Addiction Science

Addiction science is the study of how people come to use substances—or engage in behaviours—compulsively, despite harm, and of what can be done about it.

17 frameworks, from 1700 to today · Mental Health · Medicine & Health

still a working view ended · each leads to its entry below

Overview

Addiction science is the study of how people come to use substances—or engage in behaviours—compulsively, despite harm, and of what can be done about it1. It sits where medicine, psychology, pharmacology, neuroscience, economics and social policy meet, and its central puzzle is stubborn: why do people keep doing something they know is destroying them? The stakes are practical and enormous. Alcohol and drug use disorders account for a large share of preventable death and disability worldwide, and the field's theories have shaped not only clinics but also prisons, welfare rules, and whether a person is treated as sick or as bad. Its history is a long argument about that question—sin, will, disease, learning, brain, environment—in which the answers have repeatedly overlapped rather than replaced one another.

Temperance, Sin, and the Moral Model

For most of recorded history, excessive drinking and drug use were understood morally. The dominant frame in the Christian West was the moral model: addiction as vice, a failure of will and character, to be answered by exhortation, shame, penance, or punishment. This was not merely superstition. It carried a real insight—that behaviour is chosen and that people can change—and it left a durable mark on institutions, from the drunkard's disgrace to the criminal law that still governs much drug policy.

The moral model's great challenge came from the temperance movement. From the early nineteenth century, reformers argued that alcohol itself, not the drinker's weakness, was the danger. The American physician Benjamin Rush had argued in 1784 that habitual drunkenness was a disease and that spirits could be substituted with weaker drink; the temperance societies that followed pressed for abstinence as a collective solution. The movement's triumph was constitutional: the United States prohibited alcohol from 1920 to 1933 under the Eighteenth Amendment. Its failure—widespread illegal supply, organized crime, and the impossibility of enforcement—taught the field that supply and environment matter, and that moral legislation alone does not abolish demand.

The Disease Concept and the Birth of Alcoholism Treatment

The modern disease model crystallized in the 1930s. E. M. Jellinek, a biostatistician at what became the Yale Center of Alcohol Studies, studied the drinking histories of members of Alcoholics Anonymous and in 1952 published a phased account of alcoholism's development, including the idea of loss of control—that once drinking begins, the dependent person cannot reliably stop. Jellinek's work gave scientific form to a claim the medical profession had long resisted: that alcoholism is a condition with a predictable course, not simply a sin.

Alcoholics Anonymous, founded in 1935 by Bill Wilson and Bob Smith in Akron, Ohio, supplied the practical counterpart23. Its twelve steps framed recovery as surrender to a higher power, moral inventory, and mutual support, and its insistence that the alcoholic is powerless over alcohol meshed with the disease idea23. The Minnesota Model, developed from the late 1940s at centres such as Hazelden in Minnesota, combined AA's philosophy with residential treatment: group therapy, education about the disease, and abstinence as the goal. This model spread across North America and much of the world and made "treatment" for addiction a recognizable industry. Its critics noted that it rested on self-report and ideology as much as on controlled evidence, and that abstinence-only goals excluded people who might reduce rather than quit.

Behaviourism, Operant Accounts, and Behavioural Pharmacology

A rival tradition grew from experimental psychology. Behaviourists treated drug use as learned behaviour maintained by its consequences, and from the 1960s behavioural pharmacology put this to the test in the laboratory. Researchers trained animals to press levers for drug infusions, establishing that drugs such as cocaine, heroin, and alcohol function as reinforcers in the same sense as food. The operant account made two powerful moves: it showed that drug-seeking obeys general laws of learning, and it made the environment—cues, schedules, availability—a central variable rather than a backdrop.

This work produced concrete clinical tools. Contingency management, developed from the 1970s onward, pays patients in vouchers or prizes for verified abstinence; it is among the best-evidenced psychosocial treatments for stimulant use disorder, though its reliance on tangible rewards has made it politically awkward. Relapse prevention, formulated by G. Alan Marlatt in the 1980s, analysed relapse as a process triggered by high-risk situations and the "abstinence violation effect"—the spiral of guilt after a single lapse—and taught coping skills to interrupt it. These approaches treated addiction as a modifiable behaviour, not a fixed identity.

The Brain-Reward and Neurocircuitry Model

From the 1950s, neuroscience began to supply a biological mechanism. In 1954 James Olds and Peter Milner found that rats would press levers to stimulate certain brain regions, identifying what became known as the reward system—circuitry involving dopamine, centred on the nucleus accumbens and ventral tegmental area. Through the 1970s and 1980s, researchers showed that most addictive drugs raise dopamine in these pathways, and the idea took hold that addiction is a hijacking of the brain's natural reward machinery.

The model matured into the neurocircuitry (or brain disease) model, most associated with Nora Volkow, who from the 1990s used brain imaging to show altered dopamine function in people with addiction, and with the "three-stage" account—binge/intoxication, withdrawal/negative affect, and preoccupation/anticipation—elaborated by George Koob and others. The claim is that repeated drug exposure produces durable changes in circuits governing reward, stress, and self-control. The model's strength is mechanistic specificity and its political usefulness: it argues for medical treatment over punishment. Its weakness is that most people who use drugs heavily do not become addicted, and that brain changes are hard to separate from the social conditions in which they occur.

Behavioural Economics and the Disorder-of-Choice Debate

A parallel line asked why people discount the future so steeply when addicted. Behavioural economics applied to addiction—notably by Warren Bickel and by A. David Redish—showed that people with substance use disorders tend to choose small immediate rewards over larger delayed ones, a measurable "delay discounting" that predicts treatment outcomes. This reframed addiction as a disorder of choice under conditions of steep temporal discounting, not a simple absence of will.

The disorder-of-choice account, argued most prominently by the philosopher and economist Gene Heyman in Addiction: A Disorder of Choice (2009), holds that addiction is voluntary behaviour shaped by its payoffs, and that most people quit when the costs—health, family, employment—become decisive. Heyman pointed to natural recovery and to the fact that many dependent people stop without treatment. Defenders of the disease model replied that choice accounts understate compulsion and the biology of withdrawal. The debate remains live and has pushed the field toward models that combine choice, learning, and neurobiology rather than choosing one.

Social-Ecological and Risk-Environment Models

Alongside the individual-level theories, a public-health tradition emphasized context. The social-ecological model treats substance use as shaped by nested levels—individual, family, peer, community, and policy—and by what are called risk environments: the availability of substances, pricing, marketing, deprivation, and social norms. This tradition descends from epidemiology and from the temperance lesson about supply. It produced effective population measures such as alcohol taxation, restrictions on outlet density, and minimum unit pricing, and it explains why addiction rates vary so much between places and times even when individual biology does not.

Pharmacotherapy and Opioid Substitution

The most consequential medical development was pharmacological. In the 1960s, Vincent Dole and Marie Nyswander at Rockefeller University introduced methadone maintenance for heroin dependence, arguing that opioid dependence is a metabolic disorder that can be stabilized by a long-acting oral opioid, allowing patients to work and live normally. The approach was controversial—critics saw it as substituting one drug for another—but it reduced crime, overdose, and HIV transmission, and it became the backbone of opioid treatment in many countries.

Later came buprenorphine, a partial opioid agonist developed in the 1970s and approved for treatment in the 1990s, and naltrexone, an opioid antagonist used for alcohol dependence. For alcohol, disulfiram (from the 1940s) deterred drinking by making it unpleasant, while acamprosate and naltrexone offered relapse reduction with better evidence. The pharmacotherapy era established that addiction has treatable biology, and it set the stage for the current dominance of medication for opioid use disorder—even as access remains uneven and stigma persists.

Motivational Interviewing and the Shift to Client-Centred Change

In the 1980s, William Miller and Stephen Rollnick developed motivational interviewing, a directive but client-centred counselling style that helps people articulate their own reasons for change rather than confronting them4. It grew from observations that confrontational approaches often increased resistance, and it reframed ambivalence as normal. Its influence spread far beyond addiction into general health care, and it became one of the most widely taught brief interventions in the field.

Harm Reduction

The HIV epidemic of the 1980s forced a reckoning. When needle sharing drove rapid HIV transmission among people who inject drugs, public-health workers in Europe and Australia pioneered harm reduction: policies that aim to reduce the harms of drug use without requiring abstinence. Needle and syringe exchange programmes, opioid substitution therapy, supervised consumption sites, and naloxone distribution followed15. Harm reduction was fiercely contested by abstinence-oriented treatment and by moral-model politics, but it accumulated strong evidence for reducing HIV, hepatitis, and overdose death, and it is now embedded in the policy of many countries and in the World Health Organization's guidance.

The Present: Integrated Models and Open Questions

Today's addiction science is plural by design. The brain-disease model remains the dominant public framing and the basis for much funding and medication development, but it is increasingly combined with learning theory, behavioural economics, and social-ecological analysis. Contingency management, motivational interviewing, relapse prevention, and medication-assisted treatment coexist in clinical guidelines, and harm reduction sits alongside them as a public-health pillar1. The field's open questions are substantial: why most heavy users never become addicted; how to treat stimulant use disorder, for which no medication is approved; how to reduce the stigma that keeps people out of care; and how to reconcile the evidence that addiction is partly chosen with the evidence that it is partly biological. The argument that began with sin and will has not ended—it has simply acquired more instruments.

References

  1. Addiction (introduction, Harm reduction, Psychological and behavioral), Wikipedia
  2. Twelve-step program (introduction, History), Wikipedia
  3. Alcoholics Anonymous, Wikipedia
  4. Motivational interviewing, Wikipedia
  5. Harm reduction, Wikipedia

The frameworks of Addiction Science

Each framework is a way of working the field has used: when it held, and the question it answers.

  1. 1700-1950
  2. 1800-1933

    Temperance Movement

    Should alcohol be abolished by law?

    Fly to its tower in Nousfarer

  3. 1935-Present

    Disease Model of Addiction

    Is alcoholism a disease with a course?

    Fly to its tower in Nousfarer

  4. 1935-Present

    Twelve-Step and Minnesota Model

    How do people recover from addiction together?

    Fly to its tower in Nousfarer

  5. 1954-Present

    Brain-Reward and Neurocircuitry Model

    What brain changes make drug use compulsive?

    Fly to its tower in Nousfarer

  6. 1960-Present
  7. 1960-Present
  8. 1964-Present
  9. 1970-Present

    Contingency Management

    Can rewards change addictive behaviour?

    Fly to its tower in Nousfarer

  10. 1970-Present
  11. 1976-Present
  12. 1980-Present

    Relapse Prevention

    Why do people relapse and how can they cope?

    Fly to its tower in Nousfarer

  13. 1983-Present

    Motivational Interviewing

    How can conversation help people change?

    Fly to its tower in Nousfarer

  14. 1985-Present

    Harm Reduction

    How can we reduce harm without demanding abstinence?

    Fly to its tower in Nousfarer

  15. 1990-Present

    Behavioral addiction

    Can behaviours like gambling be addictions?

    Fly to its tower in Nousfarer

  16. 1990-Present

    Behavioural Economics of Addiction

    Why do addicted people discount the future?

    Fly to its tower in Nousfarer

  17. 2000-Present

How the ideas connect

Each arrow runs from an earlier idea to the later one it shaped. The list below says what passed between them.

Moral Model of AddictionTemperance MovementDisease Model of AddictionTwelve-Step and Minnesota ModelBrain-Reward and Neurocircuitry ModelBehavioural Pharmacology and Operant …Psychiatric Epidemiology and Natural …Opioid Substitution and Pharmacothera…Contingency ManagementSocial-Ecological and Risk-Environmen…Alcohol dependenceRelapse PreventionMotivational InterviewingHarm ReductionBehavioral addictionBehavioural Economics of AddictionDisorder-of-Choice Account

Beyond the field

Where Addiction Science's ideas came from in other fields, and what they led to there: the strongest 12 of 60 links.

A city in Nousfarer: a red-carpeted stair climbing terraces to a crowned tower on an acropolis, more towers round it, forest and snowy mountains beyond.
A city in Nousfarer, the game played in the browser.

Addiction Science is a planet in Nousfarer

Its city has a tower for each of these 17 frameworks. Land, walk in, and climb one concept at a time.

Land on Addiction Science

Related fields

Fields its ideas are linked to

More in Mental Health

See where Addiction Science sits on the Map of Human Knowledge